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Purpose: To search for the genetic cause of juvenile open-angle glaucoma (JOAG) in a Caucasian family and to perform
genotype/phenotype correlation studies in the kindred.
Methods: Six members of a three-generation family originating from Uzbekistan and now living in the Middle East were
recruited from one large clinic in Israel. Ophthalmologic investigations comprised of visual field assessments, intraocular
pressure measurements, optic disc evaluation, and gonioscopy. Medical charts were obtained to date the onset of glaucoma
and to evaluate aggressivity of the trait. We screened the myocilin gene (MYOC, OMIM 601652) by direct genomic
sequencing of its three exons in all family members.
Results: JOAG segregated as an autosomal dominant trait in four members of the family. The proband, a 14-year-old girl,
had been diagnosed with juvenile open-angle glaucoma at 12 years old. Her mother, maternal aunt, and maternal
grandfather all had JOAG that started at an early age. The disorder progressed rapidly even under optimal medical
treatment, and all four patients had to undergo trabeculectomy. One missense mutation, Y371D (1111t→g, Tyr [Y] 371
Asp [D]), was identified. This mutation cosegregated with the disorder in all affected members and was absent in 200
Caucasian controls. The Y371D MYOC mutation has not been reported before. One cousin of the proband was a silent
heterozygotic carrier of the mutation and was still asymptomatic at nine years of age.
Conclusions: We identified a novel mutation (Y371D) in MYOC from a Caucasian family who presented with an
aggressive form of JOAG that required early trabeculectomy. Genetic screening of the MYOC mutation was beneficial in
predicting one asymptomatic heterozygotic carrier.
Open-angle glaucoma (OAG) is the most frequent form
of glaucoma, accounting for more than half of all cases [1].
The increased frequency of OAG among relatives of patients
with  this  condition  indicates  that  its  susceptibility  is
influenced by genetic factors. Ocular hypertension (OHT)
above 21 mmHg is considered a major risk factor for OAG.
According  to  the  age  of  onset  and  aggressivity,  OAG  is
divided  into  juvenile-onset  OAG  (JOAG)  and  adult-onset
OAG. When associated with OHT, this form of OAG is known
as  primary  open-angle  glaucoma  (POAG).  JOAG  has  an
earlier age of onset, between 10 and 35 years of age, and
usually presents with high intraocular pressure (IOP), visual
field loss, and optic disc damage. JOAG often requires early
surgical treatment [2].
JOAG is typically inherited as an autosomal dominant
trait  whereas  adult-onset  POAG  is  considered  a  complex
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genetic  trait  [3,4].  More  than  20  genetic  loci  have  been
mapped  for  POAG  [3,4].  Among  these,  14  genetic  loci,
designated GLC1A to GLC1N, have been defined for JOAG
and/or  POAG  in  family-based  linkage  studies  of  several
pedigrees [3-10].
Five loci contribute to JOAG while the others exclusively
account for adult-onset POAG [3,4]. Three of these five loci,
1q21-q31  (myocilin  gene  [MYOC],  GLC1A),  9q22,  and
20p12, have been confirmed in several studies [3,4]. Two
additional  studies  have  identified  one  novel  locus  on
chromosome 15q22-q24 in one JOAG family and another on
chromosome 5q in a different JOAG family [11,12].
Myocilin (MYOC) at GLC1A has been established as a
direct  cause  of  glaucoma  [13].  In  spite  of  intensive
investigation,  its  function  remains  unknown.  MYOC  is
primarily  mutated  in  patients  with  JOAG  [13,14].
Approximately 10%–20% of all JOAG cases are caused by
mutations in MYOC [15].
MYOC consists of three exons with lengths of 604, 126,
and  782  base  pairs  (bp)  and  encodes  a  504  amino  acid
polypeptide [16]. Among 73 reported MYOC mutations, 63
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1945(86.3%)  are  located  in  exon  3  (Myocilin  allele-specific
phenotype database), suggesting that the olfactomedin-like
domain is important for POAG pathogenesis [17,18]. More
than  50%  of  these  mutations  cause  early  onset  severe
glaucoma (JOAG) whereas a few cause late-onset POAG or
even normal tension glaucoma (NTG) [19]. In Caucasians,
mutations  in  MYOC  account  for  as  many  as  36%  of  the
families with JOAG but only for 2%–4% of sporadic patients
with  POAG  [20,21].  We  herein  report  a  novel  MYOC
missense  mutation  in  a  Caucasian  family  that  causes  a
characteristic JOAG phenotype spanning three generations.
METHODS
We investigated six members of a family originating from
Uzbekistan and now living in the Middle East. When a patient
has been diagnosed before moving to the Middle East, we
obtained their ocular examination charts from the previous
hospitals or clinics where they were first investigated.
Mutation  analysis  of  MYOC  was  performed  at  the
Laboratory of Ocular Genetics and Genomics (Québec City,
Canada). Genomic DNA was extracted using the Puregene
DNA  isolation  protocol  (QIAGEN,  Mississauga,  Ontario,
Canada) from whole blood drawn by venipuncture. Three
MYOC  amplicons  were  obtained  by  polymerase  chain
reaction  (PCR)  using  the  primer  pairs  described  in  a
previously published study [21]. The myocilin genes were
screened  for  sequence  alterations  by  PCR  and  direct
sequencing  as  previously  reported  [22]  using  an  Applied
Biosystems  Prism  3730xl  DNA  Analyzer  automated
sequencer  (Applied  Biosystems  Inc,  Foster  City,  CA).
Sequence data were analyzed using the Staden preGap4 and
Gap4 programs [23]. Each familial proband was screened for
mutations in all three exons of MYOC. Sequencing of the
mutation was performed on both DNA strands.
RESULTS
Phenotypic  studies:  A  14-year-old  girl  presented  with
progressive primary open-angle glaucoma in our glaucoma
clinic two years ago when she was 12 years old. She was
diagnosed at age 10 and treated with maximal topical therapy.
Her visual acuity was then 20/20 in both eyes. Intraocular
pressure was 24 and 28 mmHg in the right and left eyes,
respectively. The anterior segment was normal on slit-lamp
examination, and the angle was wide open on gonioscopy. The
cup to disc ratio was 0.7 and 0.8 in the right and left eyes,
respectively. Visual field testing revealed damage to both
eyes. The left eye had upper and lower arcuate scotomas, and
the right eye had superior arcuate scotoma and inferior nasal
step. Trabeculectomy with mitomycin C and 5-fluorouracil
was performed in her left eye at the age of 12 years, and then
three months later, the procedure was performed in her right
eye. She had refractive hypotony after both procedures and
needed a second procedure for revision of the filter in both
eyes. Today, at 14 years old, her visual acuity is 20/30 in the
right eye and 20/20 in the left eye. Intraocular pressure (IOP)
is 7 mmHg in the right eye and 10 mmHg in the left. She has
large and raised filtering blebs. The cup to disc ratio has
improved to 0.5 in both eyes, and there is also an improvement
in the visual fields (this may seem quite unusual but possible
in children) with lower nasal arcuate scotoma in the right eye
and inferior nasal step scotoma in the left eye.
Her mother who is 32 years old, the mother’s sister who
is 36 years old, and the father of these two women also suffer
from progressive open-angle glaucoma. None of the patients
had any other ocular or systemic abnormalities. The aunt of
the  proband,  subject  II-2,  was  recently  admitted  to  our
department as an emergency with end stage glaucoma in her
only seeing (right) eye. Her visual acuity was 20/40, and the
IOP was 50 mmHg. She was known to have juvenile glaucoma
since the age of 16 in both eyes and was treated with topical
and systemic medications to lower intraocular pressures. She
became blind in her left eye after glaucoma surgery 12 years
ago at the age of 24. She recently underwent uncomplicated
trabeculectomy in her right eye, and today her visual acuity is
20/40 and intraocular pressure is 7 mmHg with a large diffuse
filtering bleb and nearly total cup to disc ratio. Her visual field
in her right eye was severely affected with only the central 10°
remaining  (tubular  vision).  The  proband’s  maternal  aunt
daugther (subject III-2), who is a nine-year-old, is currently
healthy (Table 1).
The cousin was found to be a heterozygotic carrier, and
she is currently healthy at nine years of age. She will be
followed up closely and treated if necessary. We were unable
to examine additional family members as the family had lost
contact with the husbands of the sisters and immigrated to
Israel alone.
Genotypic studies: After screening all three exons of MYOC,
a single T to G transition in exon 3 at position 1111t→g was
detected in the coding sequence of MYOC (see Figure 1, which
compares the normal and the mutated DNA sequences by ABI
tracing). This transition changes the amino acid at position
371. As this transition was absent in more than 200 control
persons (400 chromosomes) coming from all parts of the
world and as this variation cosegregated with the disorder
within the family, this Y371D change represents a mutation
in exon 3. This mutation is novel since it has not been reported
before  as  far  as  we  know  (see  Myocilin  allele-specific
phenotype database). Figure 2 shows the segregation of the
mutation  in  the  family.  This  mutation  causes  autosomal
dominant glaucoma.
DISCUSSION
We  report  a  novel  mutation  (Y371D)  in  MYOC  from  a
Caucasian family who presented with progressive open-angle
glaucoma requiring early trabeculectomy. Specific mutations
have been described in different population groups [24-29].
Cys433Arg,  which  is  thought  to  be  the  most  prevalent
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1947mutation in the Brazilian population, is associated with higher
IOP and greater vertical cup/disc ratio when compared to
patients without this mutation [28]. In Caucasian populations
originating  from  Europe,  the  most  frequently  identified
MYOC mutation is Gln368STOP, which has been reported in
1.65% of probands with POAG and has been associated with
older-onset POAG and a lower level of IOP elevation [19,22,
30].
As investigations of the molecular causes of glaucoma
are now being undertaken in populations living in the Middle-
East, it is envisaged that mutations not yet reported will be
discovered  in  disease-causing  genes.  In  this  regard,  the
Y371D  MYOC  mutation  is  novel  as  far  as  we  know.
Interestingly, since this mutation was observed in a Caucasian
family originating from Uzbekistan, it should be observed in
other regions of the world.
Determining the clinical characteristics associated with
particular MYOC mutations are essential to establish good
prognosis  and  to  initiate  the  most  appropriate  therapy.
Phenotype/genotype  correlation  studies  clearly  established
that patients carrying the MYOC Gly246Arg, Pro370Leu, or
Tyr437His mutation displayed a severe clinical presentation
appearing at a young age in children or in teenagers whereas
those harboring the Gln368Stop mutation show a mild clinical
presentation appearing at middle age or old age [24]. On the
other  hand,  a  few  MYOC  mutations  exhibit  variable
expressivity of the phenotype. For instance, Wirtz et al. [31]
described a family with an intermediate phenotype between
juvenile and adult onset glaucoma with a MYOC Asp380His
mutation  while  Morissette  et  al  [32].  reported  that  the
phenotypes associated with the MYOC Lys423Glu ranged
from juvenile-onset to adult-onset open-angle glaucoma and
showed either aggressive or mild phenotypes.
We present a family with open-angle glaucoma, which
progressed aggressively. The aggressiveness of the glaucoma
led us to perform filtering surgery in two members of this
family (proband and her aunt) in a relatively short period of
follow-up and at a younger age compared with most cases
of open-angle glaucomas. The mother of the proband was
already  blind  from  glaucoma  when  first  examined  in  our
clinic.
The primary mechanism by which the MYOC Y371D
mutation  causes  glaucoma  may  involve  misfolding  and
intracellular sequestration of the mutant protein within the
trabecular  meshwork  cell,  thereby  altering  cell-mediated
processes that control aqueous humor outflow. Indeed, several
studies  demonstrated  that  mutations  occurring  within  the
vicinity of amino acid 371 impeded secretion of heterodimers
and multimers made of mutant myocilin polypeptides from
interacting  with  their  wild-type  counterpart  [33,34].  In
particular, transfection experiments using COS-7 and human
trabecular  meshwork  cells  showed  that  myocilin  mutant
proteins,  G364V,  G367R,  P370L,  and  D380A,  were  not
secreted and remained within the intracellular milieu when
studied at 37 °C [33,35].
Our  phenotype/genotype  correlation  study  on  five
patients clearly demonstrated here that the Y371D MYOC
mutation caused juvenile onset glaucoma with a characteristic
phenotype that includes onset in the second decade of life,
usually high intraocular pressures, and a rapidly progressive
OAG disease. We also described a sixth potential patient, a
nine year-old carrier who is still asymptomatic. The gain of
Figure 1. Sequence of the region of the mutation. MYOC sequence electropherogram is shown of a wild-type unaffected subject (top panel)
and of a heterozygous patient carrying the myocilin mutation, Y371D (lower panel). Nucleotides and predicted amino acid changes are
indicated under the electropherogram. The vertical line points to the Y371D mutation.
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1948this  report  is  in  predicting  the  high  probability  that  this
asymptomatic cousin will become affected as the mutation is
fully (100%) penetrant. Finally, observation of the reported
mutation when screening for myocilin variations should help
in  managing  other  patients  and  their  families  treated  for
progressive open-angle glaucoma. This report emphasizes the
importance of taking a good family history when investigating
new glaucoma patients.
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